From defense to offense: antimicrobial peptides as promising therapeutics for cancer
- PMID: 39445062
- PMCID: PMC11496142
- DOI: 10.3389/fonc.2024.1463088
From defense to offense: antimicrobial peptides as promising therapeutics for cancer
Abstract
Antimicrobial peptides (AMPs), naturally occurring components of innate immunity, are emerging as a promising new class of anticancer agents. This review explores the potential of AMPs as a novel class of anticancer agents. AMPs, naturally occurring peptides with broad-spectrum antimicrobial activity, exhibit several characteristics that make them attractive candidates for cancer therapy, including selectivity for cancer cells, broad-spectrum activity, and immunomodulatory effects. Analysis of a dataset of AMPs with anticancer activity reveals that their effectiveness is influenced by various structural properties, including net charge, length, Boman index, and hydrophobicity. These properties contribute to their ability to target and disrupt cancer cell membranes, interfere with intracellular processes, and modulate the immune response. The review highlights the promising potential of AMPs as a new frontier in cancer treatment, offering hope for more effective and less toxic therapies. AMPs demonstrate promising potential in cancer therapy through multiple mechanisms, including direct cytotoxicity, immune response modulation, and targeting of the tumor microenvironment, as evidenced by extensive preclinical studies in animal models showing tumor regression, metastasis inhibition, and improved survival rates. AMPs show significant potential as cancer therapeutics through their direct cytotoxicity, immune response modulation, and tumor microenvironment targeting, with promising results from preclinical studies and early-phase clinical trials. Future research should focus on optimizing AMP properties, developing novel delivery strategies, and exploring synergistic combination therapies to fully realize their potential as effective cancer treatments, while addressing challenges related to stability, delivery, and potential toxicity.
Keywords: antimicrobial peptides; cancer therapy; cytotoxicity; immunomodulation; tumor.
Copyright © 2024 Zare-Zardini, Saberian, Jenča, Ghanipour-Meybodi, Jenča, Petrášová and Jenčová.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Anticancer Potential of Antimicrobial Peptides: Focus on Buforins.Polymers (Basel). 2024 Mar 7;16(6):728. doi: 10.3390/polym16060728. Polymers (Basel). 2024. PMID: 38543342 Free PMC article. Review.
-
Antimicrobial peptides: a promising frontier to combat antibiotic resistant pathogens.Ann Med Surg (Lond). 2025 Mar 27;87(4):2118-2132. doi: 10.1097/MS9.0000000000003106. eCollection 2025 Apr. Ann Med Surg (Lond). 2025. PMID: 40212220 Free PMC article. Review.
-
The application and prospects of antimicrobial peptides in antiviral therapy.Amino Acids. 2024 Dec 4;56(1):68. doi: 10.1007/s00726-024-03427-0. Amino Acids. 2024. PMID: 39630161 Free PMC article. Review.
-
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents.Int J Nanomedicine. 2024 Feb 1;19:1017-1039. doi: 10.2147/IJN.S445333. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38317847 Free PMC article. Review.
-
Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.Int J Mol Sci. 2022 Feb 24;23(5):2499. doi: 10.3390/ijms23052499. Int J Mol Sci. 2022. PMID: 35269641 Free PMC article. Review.
Cited by
-
Fluorescent Peptides Internalize HeLa Cells and Kill Multidrug-Resistant Clinical Bacterial Isolates.Antibiotics (Basel). 2025 Aug 4;14(8):793. doi: 10.3390/antibiotics14080793. Antibiotics (Basel). 2025. PMID: 40867987 Free PMC article.
-
Prediction of Chemically Modified Antimicrobial Peptides and Their Sub-functional Activities Using Hybrid Features.Probiotics Antimicrob Proteins. 2025 May 21. doi: 10.1007/s12602-025-10575-6. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40397268
-
Granzyme B and melittin in cancer immunotherapy: molecular mechanisms and therapeutic perspectives in head and neck cancers.Front Immunol. 2025 Jul 22;16:1628014. doi: 10.3389/fimmu.2025.1628014. eCollection 2025. Front Immunol. 2025. PMID: 40766321 Free PMC article. Review.
-
The Invertebrate-Derived Antimicrobial Peptide Cm-p5 Induces Cell Death and ROS Production in Melanoma Cells.Mar Drugs. 2025 Jun 29;23(7):273. doi: 10.3390/md23070273. Mar Drugs. 2025. PMID: 40710498 Free PMC article.
-
Peptide Fractions Extracted from the Hemolymph of Hermetia illucens Inhibit Growth and Motility and Enhance the Effects of Traditional Chemotherapeutics in Human Colorectal Cancer Cells.Int J Mol Sci. 2025 Feb 22;26(5):1891. doi: 10.3390/ijms26051891. Int J Mol Sci. 2025. PMID: 40076518 Free PMC article.
References
-
- Yazdi AM, Mazidi M, Tarzi MG, Zardini HZ. Investigating the toxicity of germ of date seed on normal and cancerous cell line and P53 gene expression. Acad J Health Sciences: Medicina Balear. (2023) 38:62–5.
-
- Ngoma TA, Ngoma M. Global burden of cancer. In: Kickbusch I, Ganten D, Moeti M, editors. Handbook of Global Health. Springer International Publishing, Cham: (2021). p. 459–94.
-
- Jafari Nodoshan A, Zare-Zardini H, Mosavvan M, Hashemi A, Jenabzadeh A. Analysis of pulmonary complications in pediatric acute lymphocytic leukemia patients following three years of chemotherapy treatment: A cross-sectional study. Iranian J Pediatr Hematol Oncol. (2024) 14:180–7. doi: 10.18502/ijpho.v14i3.15986 - DOI
Publication types
LinkOut - more resources
Full Text Sources